SKI Market

A+| A| A-|

Indian Indices

Sensex

75,273.45 1,205.00
( 1.63%)

Global Indices

Nasdaq

46,146.75 -82.73
(-0.18%)

Dow Jones

6,578.03 -23.97
(-0.36%)

Hang Seng

53,715.15 1,462.87
(2.80%)

Nikkei 225

9,942.10 47.95
(0.48%)

Forex

USD-INR

93.53 0.04
(0.04%)

EUR-INR

108.22 0.07
(0.07%)

GBP-INR

125.01 0.33
(0.27%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jagsonpal Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

507789

INE048B01035

37.768362

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JAGSNPHARM

28.49

1213.36

EPS(TTM)

Face Value()

Div & Yield %

6.36

1.37

Back

jubilant ingrevia ltd

Nestle India standalone net profit declines 23.64% in the September 2025 quarter

Oct 16,2025

Net profit of Nestle India declined 23.64% to Rs 753.20 crore in the quarter ended September 2025 as against Rs 986.36 crore during the previous quarter ended September 2024. Sales rose 10.95% to Rs 5630.23 crore in the quarter ended September 2025 as against Rs 5074.76 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5630.23	5074.76	11
OPM %	21.96	23.01	-
PBDT	1191.87	1142.37	4
PBT	1028.52	1020.77	1
NP	753.20	986.36	-24

75,273.45 1,205.00 ( 1.63%)

46,146.75 -82.73 (-0.18%)

6,578.03 -23.97 (-0.36%)

53,715.15 1,462.87 (2.80%)

9,942.10 47.95 (0.48%)

93.53 0.04 (0.04%)

108.22 0.07 (0.07%)

125.01 0.33 (0.27%)

0.59 0.00 (0.23%)